Cover Image
市場調查報告書

Thymosin Alpha 1中國市場分析

Investigation Report on China Thymosin Alpha 1 Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333634
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Thymosin Alpha 1中國市場分析 Investigation Report on China Thymosin Alpha 1 Market, 2010-2019
出版日期: 2015年06月25日 內容資訊: 英文 30 Pages
簡介

自Thymosin Alpha 1開發以來,使用作腫瘤免疫療法的免疫調節藥物,集聚了人們的高度關注。在臨床現場,使用於各種腫瘤 (非小細胞癌、惡性腫瘤、肝臟癌症、非何杰金氏淋巴瘤等) 的治療。在中國上市以來,Thymosin Alpha 1銷售額也急速擴大,2005年是700萬人民幣,2014年達9億6800萬人民幣,以年複合成長率(CAGR) 73.7%的速度成長。

本報告提供中國的Thymosin Alpha 1的市場相關分析、整體市場規模趨勢(過去5年份)和國內價格趨勢、各企業、各投藥形態的市場佔有率、主要製造商簡介、未來性的市場趨勢預測(今後5年份)等調查評估。

第1章 Thymosin Alpha 1相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Thymosin Alpha 1市場概況

  • 中國國內的Thymosin Alpha 1專利申請、認證情形
  • 主要製造商
  • 市場規模

第3章 Thymosin Alpha 1銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Thymosin Alpha 1市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (銷售額為基礎)
  • 市場佔有率 (銷售量為基礎)

第5章 中國的Thymosin Alpha 1市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (銷售額為基礎)
  • 各劑型的市場佔有率 (銷售量為基礎)

第6章 Thymosin Alpha 1醫院用標準價格

  • Patheon Italia S.p.A. (義大利) (商標名:Zadaxin)
  • Shanghai No.1 Biochemical Pharmaceutical Co., Ltd
  • Harbin Pharmaceutical Group Bioengineering Co., Ltd
  • Diao Group (商標名:Maipuxin)
  • Hainan Zhonghe Pharmaceutical Co., Ltd (商標名:Heri)
  • Hainan Shuangcheng Pharmaceuticals Co., Ltd (商標名:Jitai)
  • Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd

第7章 中國國內的Thymosin Alpha 1主要製造商

  • Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd
  • Hainan Shuangcheng Pharmaceuticals Co., Ltd
  • Hainan Zhonghe Pharmaceutical Co., Ltd
  • Diao Group
  • Shanghai No.1 Biochemical Pharmaceutical Co., Ltd
  • Patheon Italia S.p.A.

第8章 中國的Thymosin Alpha 1市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506239

Thymosin products which can enhance body immunity are mainly used in the treatment of hepatitis and tumor and can be categorized into thymosin (extracted), thymopentin and thymosin alpha 1, a high-end product.

First developed by SciClone Pharmaceuticals, Inc., thymosin alpha 1's being used for tumor immunotherapy as immunomodulator has increasingly gained people's attention. In the clinic, it has been used for the treatment of many kinds of tumors like non-small cell lung cancer, malignant melanoma, liver cancer, non-Hodgkin lymphomia and so on. Research has shown that thymosin alpha 1 can enhance patients' immunity, reduce side effects and infection rate, improve life quality and raise remission rate or even survival rate in the chemotherapy for tumors. As a vaccine adjuvant, thymosin alpha 1 can boost the immune response to viral vaccines like influenza vaccine and hepatitis B vaccine in patients whose immune systems are comprised or inhibited, patients with chronic hemodialysis or senile diseases included.

Thymosin alpha 1 develops fast after entering China, annual sales value rising from less than CNY 7 million in 2005 to CNY 968 million in 2014 and CAGR reaching up to 73.7%. Currently, thymosin alpha 1 in the Chinese market mainly come from Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia has the largest market share of nearly 50% for sales volume in 2014.

In the next few years, the market size of immunomodulator will grow gradually, so does that of thymosin alpha 1.

Readers can get at least the following information from this report:

  • market size of thymosin alpha 1 in China
  • competitive landscape of thymosin alpha 1 in Chinese market
  • price of thymosin alpha 1 made by different enterprises in China
  • market outlook of thymosin alpha 1 in China

The author suggests the following groups of people purchase this report:

  • manufacturers of immunomodulator
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Thymosin Alpha 1

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Thymosin Alpha 1 in China

  • 2.1. Patent and Approval Status of Thymosin Alpha 1 in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Thymosin Alpha 1 in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Thymosin Alpha 1 in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Thymosin Alpha 1 in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Thymosin Alpha 1 in Chinese Hospitals in 2014

  • 6.1. Patheon Italia S.p.A. (IT) (Trade Name: Zadaxin)
  • 6.2. Shanghai No.1 Biochemical Pharmaceutical Co., Ltd
  • 6.3. Harbin Pharmaceutical Group Bioengineering Co., Ltd
  • 6.4. Diao Group (Trade Name: Maipuxin)
  • 6.5. Hainan Zhonghe Pharmaceutical Co., Ltd (Trade Name: Heri)
  • 6.6. Hainan Shuangcheng Pharmaceuticals Co., Ltd (Trade Name: Jitai)
  • 6.7. Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd

7. Major Manufacturers of Thymosin Alpha 1 in Chinese Market, 2010-2014

  • 7.1. Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd
  • 7.2. Hainan Shuangcheng Pharmaceuticals Co., Ltd
  • 7.3. Hainan Zhonghe Pharmaceutical Co., Ltd
  • 7.4. Diao Group
  • 7.5. Shanghai No.1 Biochemical Pharmaceutical Co., Ltd
  • 7.6. Patheon Italia S.p.A.

8. Market Outlook of Thymosin Alpha 1 in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Registration Information of Related Medicines of Thymosin Alpha 1
  • Chart Sales Status of Thymosin Alpha 1 in China, 2010-2014
  • Chart Sales Value of Thymosin Alpha 1 in China, 2010-2014
  • Chart Sales Value of Thymosin Alpha 1 in Some Regions in China, 2010-2014
  • Chart Sales Volume of Thymosin Alpha 1 in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Thymosin Alpha 1 for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Thymosin Alpha 1 Made by Patheon Italia(IT) in China, 2010-2014
  • Chart Sales Value and Market Share of Thymosin Alpha 1 Made by Diao in China, 2010-2014
  • Chart Sales Value and Market Share of Thymosin Alpha 1 Made by Hainan Shuangcheng in China, 2010-2014
  • Chart Sales Value and Market Share of Thymosin Alpha 1 Made by Hainan Zhonghe in China, 2010-2014
  • Chart Sales Value and Market Share of Thymosin Alpha 1 Made by Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical in China, 2010-2014
  • Chart Price of Thymosin Alpha 1 Made by Patheon Italia S.p.A. (IT) in Some Chinese Cities in 2014
  • Chart Price of Thymosin Alpha 1 Made by Shanghai No.1 Biochemical Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thymosin Alpha 1 Made by Harbin Pharmaceutical Group Bioengineering Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thymosin Alpha 1 Made by Diao Group in Some Chinese Cities in 2014
  • Chart Price of Thymosin Alpha 1 Made by Hainan Zhonghe Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thymosin Alpha 1 Made by Hainan Shuangcheng Pharmaceuticals Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thymosin Alpha 1 Made by Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top